Skip to content

Home
About us
Insights
Stocks
Compliance
Special Services
Contact
LanguageEN BR

EN

EN BR

Tag: EMS

Insights

Anvisa Approves EMS’s Ozivy, Brazil’s First Semaglutide Pen

26 de May de 2026
Insights

Anvisa aprova Ozivy, da EMS, primeira caneta semaglutida brasileira

26 de May de 2026
Insights

EMS to Buy Medley for $600 Million, Deal Set to Face Cade Scrutiny

6 de March de 2026

Brazil Stock Guide

The most comprehensive resource for portfolio managers and investors focused on emerging markets — with a special emphasis on Brazil. In-depth analysis, curated insights, and data-driven perspectives on Latin America’s largest economy.

Navigate

Home
About us
Insights
Compliance
Contact

Follow

X
Instagram
LinkedIn
Facebook

© Brazil Stock Guide. All rights reserved.